Your browser doesn't support javascript.
loading
Naturally acquired antibodies to merozoite surface protein (MSP)-1(19) and cumulative exposure to Plasmodium falciparum and Plasmodium vivax in remote populations of the Amazon Basin of Brazil
Ladeia-Andrade, Simone; Ferreira, Marcelo Urbano; Scopel, Kézia Katiani Gorza; Braga, Érika Martins; Bastos, Melissa da Silva; Wunderlich, Gerhard; Coura, José Rodrigues.
  • Ladeia-Andrade, Simone; Fiocruz. Instituto Oswaldo Cruz. Laboratório de Doenças Parasitárias. Rio de Janeiro. BR
  • Ferreira, Marcelo Urbano; Universidade de São Paulo. Instituto de Ciências Biomédicas. Departamento de Parasitologia. São Paulo. BR
  • Scopel, Kézia Katiani Gorza; Universidade Federal de Minas Gerais. Instituto de Ciências Biomédicas. Departmento de Parasitologia. Belo Horizonte. BR
  • Braga, Érika Martins; Universidade Federal de Minas Gerais. Instituto de Ciências Biomédicas. Departmento de Parasitologia. Belo Horizonte. BR
  • Bastos, Melissa da Silva; Universidade de São Paulo. Instituto de Ciências Biomédicas. Departamento de Parasitologia. São Paulo. BR
  • Wunderlich, Gerhard; Universidade de São Paulo. Instituto de Ciências Biomédicas. Departamento de Parasitologia. São Paulo. BR
  • Coura, José Rodrigues; Fiocruz. Instituto Oswaldo Cruz. Laboratório de Doenças Parasitárias. Rio de Janeiro. BR
Mem. Inst. Oswaldo Cruz ; 102(8): 943-951, Dec. 2007. mapas, tab
Article in English | LILACS | ID: lil-471861
ABSTRACT
To infer recent patterns of malaria transmission, we measured naturally acquired IgG antibodies to the conserved 19-kDa C-terminal region of the merozoite surface protein (MSP)-1 of both Plasmodium vivax (PvMSP-1(19)) and Plasmodium falciparum (PfMSP-1(19)) in remote malaria-exposed populations of the Amazon Basin. Community-based cross-sectional surveys were carried out between 2002 and 2003 in subjects of all age groups living along the margins of the Unini and Jaú rivers, Northwestern Brazil. We found high prevalence rates of IgG antibodies to PvMSP-1(19) (64.0 - 69.6 percent) and PfMSP-1(19) (51.6 - 52.0 percent), with significant differences in the proportion of subjects with antibodies to PvMSP-1(19) according to age, place of residence and habitual involvement in high-risk activities, defining some groups of highly exposed people who might be preferential targets of malaria control measures. In contrast, no risk factor other than age was significantly associated with seropositivity to PfMSP-1(19). Only 14.1 percent and 19.3 percent of the subjects tested for antibodies to PvMSP-1(19) and PfMSP-1(19) in consecutive surveys (142 - 203 days apart) seroconverted or had a three fold or higher increase in the levels of antibodies to these antigens. We discuss the extent to which serological data correlated with the classical malariometric indices and morbidity indicators measured in the studied population at the time of the seroprevalence surveys and highlight some limitations of serological data for epidemiological inference.
Subject(s)

Full text: Available Index: LILACS (Americas) Main subject: Plasmodium falciparum / Plasmodium vivax / Antibodies, Protozoan / Malaria, Vivax / Malaria, Falciparum / Merozoite Surface Protein 1 Type of study: Risk factors Limits: Animals / Humans Country/Region as subject: South America / Brazil Language: English Journal: Mem. Inst. Oswaldo Cruz Journal subject: Tropical Medicine / Parasitology Year: 2007 Type: Article Affiliation country: Brazil Institution/Affiliation country: Fiocruz/BR / Universidade Federal de Minas Gerais/BR / Universidade de São Paulo/BR

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Plasmodium falciparum / Plasmodium vivax / Antibodies, Protozoan / Malaria, Vivax / Malaria, Falciparum / Merozoite Surface Protein 1 Type of study: Risk factors Limits: Animals / Humans Country/Region as subject: South America / Brazil Language: English Journal: Mem. Inst. Oswaldo Cruz Journal subject: Tropical Medicine / Parasitology Year: 2007 Type: Article Affiliation country: Brazil Institution/Affiliation country: Fiocruz/BR / Universidade Federal de Minas Gerais/BR / Universidade de São Paulo/BR